Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

NCT04464200

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +41 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.

NCT05788081

Conditions
Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV, +10 more
Locations
  • Grampians Health Ballarat, Victoria, Australia
  • Eastern Health Box Hill, Victoria, Australia
  • University Hospital Geelong, Barwon Health Geelong, Victoria, Australia
  • Austin Health Heidelberg, Victoria, Australia
View Trial Details
Active, Not Recruiting

Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae

NCT04541056

Conditions
Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia, Childhood Non-Hodgkin Lymphoma, +11 more
Locations
  • Oslo University Hospital - Rikshospitalet Oslo, Norway
  • St. Olavs Hospital Trondheim, Norway
  • Department of Psychology, Norwegian University of Science and Technology (NTNU) Trondheim, Norway
View Trial Details
Active, Not Recruiting

Severe Asthma Research Program

NCT01606826

Conditions
Asthma, Bronchial Diseases, Hemic and Lymphatic Diseases, +15 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Children's Hospital, Boston Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

NCT03314181

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Univ of Colorado Cancer Center /ID# 167331 Aurora, Colorado, United States
  • Moffitt Cancer Center /ID# 169614 Tampa, Florida, United States
  • Winship Cancer Institute of Emory University /ID# 165427 Atlanta, Georgia, United States
  • The University of Chicago Medical Center /ID# 165429 Chicago, Illinois, United States
View all 40 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets

NCT05308654

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Stanford University School of Med /ID# 242809 Stanford, California, United States
  • Sylvester Comprehensive Cancer Center /ID# 243417 Miami, Florida, United States
  • Tulane University School of Medicine /ID# 244854 New Orleans, Louisiana, United States
  • American Oncology Partners of Maryland /ID# 244858 Bethesda, Maryland, United States
View all 21 locations
View Trial Details

Related conditions